Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem Americas, Inc.
02 1PolyPeptide Laboratories Private Limited
01 2Deslorelin
01 2Switzerland
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 52416-110
Start Marketing Date : 2003-11-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59149-003
Start Marketing Date : 2023-02-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (3g/3g)
Marketing Category : BULK INGREDIENT
A Deslorelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deslorelin, including repackagers and relabelers. The FDA regulates Deslorelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deslorelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deslorelin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deslorelin supplier is an individual or a company that provides Deslorelin active pharmaceutical ingredient (API) or Deslorelin finished formulations upon request. The Deslorelin suppliers may include Deslorelin API manufacturers, exporters, distributors and traders.
click here to find a list of Deslorelin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deslorelin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Deslorelin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Deslorelin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Deslorelin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deslorelin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Deslorelin suppliers with NDC on PharmaCompass.
We have 2 companies offering Deslorelin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
